Intelligence · Clinical pipeline
Metabolic & obesity · Approved programs
Metabolic & obesity programs at Approved programs — ClinicalTrials.gov pipeline intelligence.
Quick answer
Metabolic & obesity Approved programs programs: NovaPharmaNews indexes 105 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.
Top sponsors
- Takeda 21 programs
- First People's Hospital 15 programs
- Disc Medicine 7 programs
- Regeneron UK 7 programs
- George Institute for 5 programs
- Chinese Academy of 4 programs
- Hospital Authority 4 programs
- Sanofi Pasteur MSD 4 programs
- ANI PHARMACEUTICALS 3 programs
- Eli Lilly and 3 programs
- HALOZYME THERAPEUTICS 3 programs
- NovoThirteen 3 programs
Pipeline programs
-
116795
Disc Medicine
Type 1 Diabetes
1 trial -
18253
Disc Medicine
Albuminuria, Type 2 diabetes
1 trial -
AD-4833 15 mg
Takeda
Diabetes Mellitus
1 trial -
ANGELO
The George Institute
Obesity
1 trial -
Aflibercept
Regeneron UK Limited
Diabetic Macular Edema
2 trials -
Aflibercept
Regeneron UK Limited
Diabetic Retinopathy
2 trials -
Aflibercept (BAY86-5321, Eylea)
Regeneron UK Limited
Diabetic Macular Edema
1 trial -
Aflibercept 8 mg (VEGF Trap-Eye, BAY86-5321)
Regeneron UK Limited
Diabetic Macular Edema (DME)
1 trial -
Aflibercept Injection
Regeneron UK Limited
Diabetic Retinopathy
2 trials -
Alogliptin
Takeda
Diabetes Mellitus, Type 2
6 trials -
Azilsartan
Takeda
Essential Hypertension Complicated by Type 2 Diabetes Mellitus
1 trial -
Berberine
The First People's Hospital of Lianyungang
Diabetes Mellitus
1 trial -
Berberine plus lifestyle intervention
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Obesity
1 trial -
BioPhenoT2D
Fondazione Telethon ETS
type 2 diabetes
1 trial -
Blood Glucose Meter Systems
Universal Integrated
Diabetes
1 trial -
Breeze2 glucometer
Hospital Authority, Hong Kong
Diabetes
1 trial -
CSII
The First People's Hospital of Lianyungang
Diabetes Mellitus, Type 2
1 trial -
Candesartan and Hydrochlorothiazide
Takeda
Obesity
1 trial -
Commercial Hylenex® recombinant (hyaluronidase human injection)
HALOZYME THERAPEUTICS, INC.
Type 1 Diabetes Mellitus
1 trial -
DON3
Fondazione Telethon ETS
obese elderly people with vitamin D deficiency
1 trial -
Dapagliflozin
AstraZeneca
Diabetes Mellitus, Type 2
1 trial -
Dapagliflozin 10 MG
The First People's Hospital of Lianyungang
Type 2 Diabetes Mellitus
1 trial -
EPHIC-DIA2
The George Institute
Type 2 Diabetes Mellitus
1 trial -
ESOMEPRAZOLE, ESOMEPRAZOLE
Fondazione Telethon ETS
obesity
1 trial -
EXPAREL
Pacira Ireland Limited
Obesity
1 trial -
Exenatide
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Type 2 Diabetes Mellitus
1 trial -
Exenatide
The First People's Hospital of Lianyungang
Type 2 Diabetes
1 trial -
Eylea 114.3 mg/ml solution for injection
Bayer AG
Neovascular age-related macular degeneration (nAMD), Diabetic macular edema (DME)
1 trial -
Fenofibrate 145 mg
United Therapeutics Europe Ltd
Diabetic Retinopathy
1 trial -
Fespixon Cream
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Diabetic Foot Ulcer (DFU)
1 trial -
Finerenone
Chinese University of Hong Kong
Patients With Type 2 Diabetes
1 trial -
Glucagon-like peptide-1 receptor agonist：Semaglutide
The First People's Hospital of Lianyungang
Type 2 Diabetes
1 trial -
Henagliflozin Proline Tablets treatment
The First People's Hospital of Lianyungang
Diabetes Type 2
1 trial -
ILUVIEN
ANI PHARMACEUTICALS INC
Chronic Diabetic Macular Edema
1 trial -
ILUVIEN 0.19 MG
ANI PHARMACEUTICALS INC
Diabetic Macular Edema (DME)
1 trial -
INSULIN GLARGINE
Sanofi-aventis Healthcare Pty Ltd
Diabetes mellitus II
1 trial -
INSULIN GLARGINE (HOE901)
Sanofi Pasteur
Diabetes Mellitus, Type 2
1 trial -
IVC
The First People's Hospital of Lianyungang
Proliferative Diabetic Retinopathy
1 trial -
Iluvien 0.19 MG Drug Implant
ANI PHARMACEUTICALS INC
Diabetic Macular Edema
1 trial -
Insulin Glargine
Eli Lilly and Company
Diabetes Mellitus, Type 2
1 trial -
Insulin Glargine
Sanofi Pasteur
Diabetes Mellitus, Type 2
2 trials -
Insulin glulisine
Sanofi Pasteur
Diabetes Mellitus, Type 1
1 trial -
Insulin lispro low mixture
Eli Lilly and Company
Type 2 Diabetes Mellitus
1 trial -
Intravenous Ibuprofen
CUMBERLAND PHARMACEUTICALS INC
Obesity
1 trial -
Intravitreal Aflibercept
Regeneron UK Limited
Diabetic Macular Edema
2 trials -
Liraglutide
Sana Biotechnology
Morbid Obesity
1 trial -
Lixisenatide (AVE0010)
Sanofi Pasteur
Diabetes Mellitus, Type 2
3 trials -
Maggot debridement therapy
The First People's Hospital of Lianyungang
Diabetic Foot Ulcers
1 trial
Frequently asked questions
How many metabolic & obesity Approved programs programs exist?
105 programs match both the therapeutic area and stage filters in our published index.